Skip to main content

Published locations for Neoadjuvant letrozole-palbociclib combo might allow sparing chemotherapy in high-risk ER+/HER2- early breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Neoadjuvant letrozole-palbociclib combo might allow sparing chemotherapy in high-risk ER+/HER2- early breast cancer

User login

  • Reset your password
  • /content/neoadjuvant-letrozole-palbociclib-combo-might-allow-sparing-chemotherapy-high-risk-er/her2
  • /hematology-oncology/article/254053/breast-cancer/neoadjuvant-letrozole-palbociclib-combo-might-allow
  • /breast-cancer-icymi/article/254053/breast-cancer/neoadjuvant-letrozole-palbociclib-combo-might-allow